NOVAVAX INC Quarterly Net Income (Loss) Attributable to Parent in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Novavax Inc quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2010 to Q3 2024.
  • Novavax Inc Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$121M, a 7.25% increase year-over-year.
  • Novavax Inc Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$285M, a 48.1% increase year-over-year.
  • Novavax Inc annual Net Income (Loss) Attributable to Parent for 2023 was -$545M, a 17.2% increase from 2022.
  • Novavax Inc annual Net Income (Loss) Attributable to Parent for 2022 was -$658M, a 62.3% increase from 2021.
  • Novavax Inc annual Net Income (Loss) Attributable to Parent for 2021 was -$1.74B, a 317% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$285M -$121M +$9.48M +7.25% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 -$294M $162M +$104M +180% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 -$399M -$148M +$146M +49.8% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q4 2023 -$545M -$178M +$3.86M +2.12% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-28
Q3 2023 -$549M -$131M +$37.8M +22.4% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 -$587M $58M +$568M Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 -$1.16B -$294M -$497M -244% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 -$658M -$182M +$664M +78.5% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-28
Q3 2022 -$1.32B -$169M +$154M +47.7% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$1.48B -$510M -$158M -44.9% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 -$1.32B $203M +$426M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 -$1.74B -$846M -$669M -377% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-28
Q3 2021 -$1.08B -$322M -$125M -63.4% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 -$950M -$352M -$335M -1911% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 -$615M -$223M -$197M -761% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 -$418M -$178M -$146M -458% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-28
Q3 2020 -$273M -$197M -$179M -994% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-05
Q2 2020 -$93.3M -$17.5M +$22.1M +55.8% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 -$115M -$25.9M +$17.4M +40.2% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q4 2019 -$133M -$31.8M +$17.5M +35.5% Oct 1, 2019 Dec 31, 2019 10-K 2020-03-11
Q3 2019 -$150M -$18M +$26.5M +59.5% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-10
Q2 2019 -$177M -$39.6M +$4.89M +11% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 -$182M -$43.2M +$3.13M +6.76% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 -$185M -$49.3M +$1.51M +2.97% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-11
Q3 2018 -$186M -$44.6M +$37K +0.08% Jul 1, 2018 Sep 30, 2018 10-K 2020-03-11
Q2 2018 -$186M -$44.5M -$27K -0.06% Apr 1, 2018 Jun 30, 2018 10-K 2020-03-11
Q1 2018 -$186M -$46.4M -$2.5M -5.7% Jan 1, 2018 Mar 31, 2018 10-K 2020-03-11
Q4 2017 -$184M -$50.8M +$6.27M +11% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-18
Q3 2017 -$190M -$44.6M +$21.6M +32.7% Jul 1, 2017 Sep 30, 2017 10-K 2019-03-18
Q2 2017 -$212M -$44.5M +$34.9M +44% Apr 1, 2017 Jun 30, 2017 10-K 2019-03-18
Q1 2017 -$247M -$43.9M +$33.4M +43.2% Jan 1, 2017 Mar 31, 2017 10-K 2019-03-18
Q4 2016 -$280M -$57.1M +$21.7M +27.5% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-14
Q3 2016 -$302M -$66.3M -$33.1M -100% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-14
Q2 2016 -$269M -$79.4M -$58.7M -284% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-14
Q1 2016 -$210M -$77.3M -$52.9M -217% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-14
Q4 2015 -$157M -$78.8M -$47.3M -150% Oct 1, 2015 Dec 31, 2015 10-K 2017-02-27
Q3 2015 -$110M -$33.1M -$13.4M -67.9% Jul 1, 2015 Sep 30, 2015 10-K 2017-02-27
Q2 2015 -$96.3M -$20.6M -$2.78M -15.5% Apr 1, 2015 Jun 30, 2015 10-K 2017-02-27
Q1 2015 -$93.5M -$24.4M -$10.6M -76.5% Jan 1, 2015 Mar 31, 2015 10-K 2017-02-27
Q4 2014 -$82.9M -$31.5M -$17.5M -124% Oct 1, 2014 Dec 31, 2014 10-K 2016-02-29
Q3 2014 -$65.5M -$19.7M -$4.43M -28.9% Jul 1, 2014 Sep 30, 2014 10-K 2016-02-29
Q2 2014 -$61M -$17.9M -$5.23M -41.4% Apr 1, 2014 Jun 30, 2014 10-K 2016-02-29
Q1 2014 -$55.8M -$13.8M -$3.81M -38.2% Jan 1, 2014 Mar 31, 2014 10-K 2016-02-29
Q4 2013 -$52M -$14.1M -$6.02M -74.9% Oct 1, 2013 Dec 31, 2013 10-K 2015-02-27
Q3 2013 -$46M -$15.3M -$8.08M -112% Jul 1, 2013 Sep 30, 2013 10-K 2015-02-27
Q2 2013 -$37.9M -$12.6M -$6.71M -113% Apr 1, 2013 Jun 30, 2013 10-K 2015-02-27
Q1 2013 -$31.2M -$10M -$2.66M -36.3% Jan 1, 2013 Mar 31, 2013 10-K 2015-02-27
Q4 2012 -$28.5M -$8.03M -$4.33M -117% Oct 1, 2012 Dec 31, 2012 10-K 2015-02-27
Q3 2012 -$24.2M -$7.22M -$4.01M -125% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-12
Q2 2012 -$20.2M -$5.92M -$927K -18.6% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-08
Q1 2012 -$19.2M -$7.34M +$117K +1.57% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-09
Q4 2011 -$19.4M -$3.71M Oct 1, 2011 Dec 31, 2011 10-K 2014-03-12
Q3 2011 -$3.21M +$7.01M +68.6% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-09
Q2 2011 -$4.99M +$3.86M +43.6% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-09
Q1 2011 -$7.45M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-09
Q3 2010 -$10.2M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-08
Q2 2010 -$8.86M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.